清木丹颗粒联合普通干扰素对慢乙肝患者血清HBsAg滴度影响临床观察.pdfVIP

Detoxification Treatment Quyu Guben Noxious Heat Stasis purpura nephritis type Clinical trials Abstract Henoch-Schonlein purpura nephritis (thenephritisofHenoeh a Sehonleinpurpura, HSpN), allergic purpura is secondary to glomerular disease after, referred to as purpura nephritis. Henoch-Schonlein purpura is a complication of skin to the body or limbs, with or without purpura purpura, purpura, or after the onset of edema, hematuria and proteinuria as the main manifestation of secondary renal disease. Henoch-Schonlein purpura nephritis pathogenesis has not yet entirely clear, but now is a clear cycle with IgA immune complex deposition in the body caused by multiple small blood vessels and capillaries of the immune complex diseases, especially IgA circulating poly- immune complexes exist. It may be related to infections and allergy [1]. Henoch-Schonlein purpura currently no specific treatment for nephritis, the treatment principles for the removal of the cause, anti-allergic, immunosuppressive therapy and symptomatic treatment [2]. And the traditional use of corticosteroid and cytotoxic effect of inaccurate and highly toxic [3]. In conclusion, chief physician mentor Pan Long years of experience in clinical practice, according to its incidence is put forward as the main detoxification therapy stasis consolidate in order to improve the clinical efficacy of the disease, in Clinical many effective. Therefore, we consolidate Quyu soup for detoxification clinical trials of the drug for observation has been confirmed by renal biopsy of mesangial proliferative nephritis allergic purpura 24-hour urine protein, clinical symptoms and safety observations provide experimental basis for clinical treatment. Objective: The clinical trial, observed detoxification Treatment Quyu Guben allergic purpura nephritis